Targeted and responsive biomaterials in osteoarthritis

Таргетные и реагирующие биоматериалы при остеоартрите
Jiadong Li, Jiacan Su, Yan Hu, Zhen Geng, Yafei Han, Hao Zhang
2023-01-01

controlled releasedrug targetingosteoarthritisresponsive biomaterialstargeted biomaterials
Osteoarthritis (OA) is a degenerative disease characterized by loss of articular cartilage and chronic inflammation, involving multiple cellular dysfunctions and tissue lesions. The non-vascular environment and dense cartilage matrix in the joints tend to block drug penetration, resulting in low drug bioavailability. There is a desire to develop safer and more effective OA therapies to meet the challenges of an aging world population in the future. Biomaterials have achieved satisfactory results in improving drug targeting, prolonging the duration of action, and achieving precision therapy. This article reviews the current basic understanding of the pathological mechanisms and clinical treatment dilemmas of OA, summarizes and discusses the advances for different kinds of targeted and responsive biomaterials in OA, seeking to provide new perspectives for the treatment of OA. Subsequently, limitations and challenges in clinical translation and biosafety are analyzed to guide the development of future therapeutic strategies for OA. As the need for precision medicine rises over time, emerging multifunctional biomaterials based on tissue targeting and controlled release will become an irreplaceable part of OA management.
1
Multifunctional biomaterials integrating tissue targeting with controlled release are expected to become increasingly important for precision osteoarthritis management.
2
Osteoarthritis involves cartilage loss, chronic inflammation, multiple cellular dysfunctions, and diverse tissue lesions, complicating treatment development.
3
Targeted and responsive biomaterials can improve drug localization, prolong therapeutic action, and enable more precise osteoarthritis treatment.
4
The avascular joint environment and dense cartilage matrix impede drug penetration and reduce local drug bioavailability.
5
The review summarizes advances in tissue-targeted and stimulus-responsive biomaterials for osteoarthritis therapy while identifying clinical translation and biosafety challenges.

targeted and responsive biomaterials for osteoarthritis therapy

their tissue targeting, controlled drug release, therapeutic efficacy, and clinical translation challenges in osteoarthritis

Publication Details
Publication Date
2023-01-01
Journal
Publisher
ISSN
Cited by
150
Access Type
Author Information
Authors
Jiadong Li
Jiacan Su
Yan Hu
Zhen Geng
Yafei Han
Hao Zhang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%